一种深度生成模型,用于解读细胞动态和在复杂疾病中进行in silico药物发现
Yumin Zheng1,2, Jonas C Schupp3,4,5, Taylor Adams3
1Quantitative Life Sciences, Faculty of Medicine & Health Sciences, McGill University, Montreal, Quebec, Canada.
Nature biomedical engineering
|June 20, 2025
概括
我们开发了UNAGI,这是一个深度神经网络,用于分析单细胞转录组数据,以了解疾病进展和预测药物反应. 它确定了针对异常性肺纤维化症的潜在抗纤维药物.
科学领域:
- 计算生物学是一种计算生物学.
- 基因组学就是基因组学.
- 药物发现 药物发现
背景情况:
- 单细胞转录组学为人类疾病提供了洞察力,但缺乏用于疾病进展分析和in silico药物干预的先进计算工具.
- 在疾病中分析复杂的细胞动态需要复杂的计算方法.
研究的目的:
- 介绍UNAGI,一个深度生成神经网络,旨在分析时间序列单细胞转录组数据.
- 增强疾病进展建模和in silico药物查能力.
- 确定复杂疾病的潜在治疗点和候选药物.
主要方法:
- 开发UNAGI,用于时间序列单细胞转录组数据分析的深度生成神经网络.
- 将UNAGI应用于异常性肺纤维化 (IPF) 患者数据,以学习疾病信息的细胞嵌入.
- 使用蛋白质学和人类精确切割肺切片模型验证UNAGI的预测.
- 在COVID-19数据上测试UNAGI的适应能力.
主要成果:
- UNAGI有效地捕捉了疾病进展中的复杂细胞动态.
- 该工具确定了IPF的潜在治疗药物候选者,包括尼费迪平,其在人类肺组织中已证实具有抗纤维作用.
- 蛋白质组验证证实了UNAGI的细胞动态分析的准确性.
- 乌纳吉 (UNAGI) 证明了对其他疾病如COVID-19的多功能性和适用性.
结论:
- UNAGI提供了一种强大的计算工具,用于解码疾病进展中的复杂细胞动态.
- 它增强了in silico药物干扰建模和查,加速了治疗发现.
- UNAGI在各种病理场景中显示出广泛的适用性,有助于寻找新型治疗方法.
更多相关视频
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
6.5K
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
3.0K
相关概念视频
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...